Johnson & Johnson Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries, Amount (Deprecated 2011-01-31)
Johnson & Johnson (JNJ) had Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries, Amount (Deprecated 2011-01-31) of $45.85 billion as of 2011-01-02, per its 10-K filed 2011-02-25.
Discontinued › Notes › Segment Reporting
us-gaap:EntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesAmount · last filed 2011-02-25
- 2011-01-02: Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries, Amount (Deprecated 2011-01-31) $45.85B.
- 2010-01-03: Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries, Amount (Deprecated 2011-01-31) $45.15B.
- 2008-12-28: Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries, Amount (Deprecated 2011-01-31) $41.27B.
| Period end | Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries, Amount (Deprecated 2011-01-31) |
|---|---|
| 2011-01-02 | $45.85B 10-K · filed 2011-02-25 |
| 2010-01-03 | $45.15B 10-K · filed 2011-02-25 |
| 2008-12-28 | $41.27B 10-K · filed 2011-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |